Research and Markets: Richter is One of the Last Major CEE Pharmaceutical Manufacturers Not to Be Acquired by a Multinational Manufacturer.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45967) has announced the addition of "Gedeon Richter Generics Company Intelligence Report" to their offering. Gedeon Richter was founded in 1901 in Hungary, and is that country's largest drug manufacturer. During the Communist era, it was one of the leading suppliers of pharmaceuticals within the Soviet Bloc, and remains a leading player in the Russian market. Around two thirds of revenues are still generated in central and eastern Europe The term "Central and Eastern Europe" came into wide spread use, replacing "Eastern bloc", to describe former Communist countries in Europe, after the collapse of the Iron Curtain in 1989/90. . Sales in 2005 amounted to HUF HUF In currencies, this is the abbreviation for the Hungarian Forint. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 140,895.0 million, a rise of 15.9% over 2004. Drugs are sold in Hungary and other CEE cee n. The letter c. markets as branded generics. These are often under patent in western markets, due to the CEE region's historic lack of patent protection for pharmaceuticals. The company is keen to expand into western markets. Richter has only a limited direct presence in the USA; it currently only holds one ANDA ANDA abbr. abbreviated new drug application , for fluconazole fluconazole /flu·con·a·zole/ (floo-kon´ah-zol) a triazoleantifungal used in the systemic treatment of candidiasis and cryptococcal meningitis. flu·con·a·zole n. . It does, however, have supply agreements with a number of US generic companies, including Barr Laboratories and IVAX IVAX Industrial Vax (Dec Computer) . Richter also acts as a distributor for foreign originator companies. Its largest distributed product is Avonex (interferon beta-1a interferon beta-1a Avonex, Rebif Pharmacologic class: Biological response modifier Therapeutic class: Antiviral, immunoregulator Pregnancy risk category C Action), which it sells for Biogen in a number of CEE markets.Richter is one of the last major CEE pharmaceutical manufacturers not to be acquired by a multinational manufacturer; almost all the other Hungarian manufacturers are now owned by foreign companies. These generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the company's active product lines and ANDA approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . The easy and cost effective way to monitor developments in leading generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. industry players. Generics Company Reports are packed with facts, figures and statistics, providing you with the most thorough ongoing monitoring of the important generic companies. From financial performance to litigation, no other service provides such comprehensive insight to the companies driving growth in this rapidly expanding area of the pharmaceutical industry. Each report is updated and issued every quarter. This ongoing monitoring and regular delivery ensures that developments are incorporated into the relevant reports. This vigilance ensures that whether it's the latest deals, ANDAs, alliances or litigation you can assess the impact of the development in the context of the company, its competitors and the broader market. Use Generic Company Reports to: * Evaluate the competitive operating environment In computing, an operating environment is the environment in which users run programs, whether in a command line interface, such as in MS-DOS or the Unix shell, or in a graphical user interface, such as in the Macintosh operating system. . * Identify which companies are applying for ANDAs, and for what. * Understand generic companies' product line up. * Monitor the financial performance of leading generics players. * Track the twists and turns of litigation. Stay in touch with the latest M&A and strategic alliances Topics Covered: * Products * Financial results * Major developments * Mergers, acquisitions and agreements * Litigation Companies Mentioned: * Richter * Barr Laboratories * Biogen For more information visit http://www.researchandmarkets.com/reports/c45967 Source: Espicom |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion